Patent · US Active

Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase

US9133191B2 · kind B2 · utility

5Cited by

15References

7Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Markus Follmann
Johannes-Peter Stasch · Wuppertal, DE
Gorden Redlich · Bochum, DE
Nils Griebenow · Milford, US
Frank Wunder · Wuppertal, DE
Dieter Lang · Velbert, DE

Key dates

Filing date	Jan 8, 2013
Grant date	Sep 15, 2015
Priority date	—
Expiry date	Jan 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to novel substituted fused pyrimidines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.